Herbs commonly used by women: An evidence-based review

American Journal of Obstetrics and Gynecology

Volumn 188, Issue 5 SUPPL., 2003, Pages

  Tesch, Bonnie J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Alternative medicine; Herbal medicine; Herbs; Phytomedicine

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIOXIDANT; CIMICIFUGA RACEMOSA EXTRACT; CONJUGATED ESTROGEN; ECHINACEA EXTRACT; FLUOXETINE; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HEAVY METAL; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; IMIPRAMINE; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN RADICAL; RESERPINE; SCOPOLAMINE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; STEROID; THEOPHYLLINE; THROMBOCYTE ACTIVATING FACTOR; UNINDEXED DRUG; VALERIAN; VITAMIN; VITEX AGNUS CASTUS EXTRACT; WARFARIN;

ALTITUDE DISEASE; ATHEROSCLEROSIS; BLEEDING; BRAIN DYSFUNCTION; CANCER; CARDIOVASCULAR DISEASE; CLAUDICATION; CLINICAL TRIAL; COMMON COLD; DEMENTIA; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; FEMALE; FOOD AND DRUG ADMINISTRATION; GARLIC; GASTROINTESTINAL SYMPTOM; GINKGO BILOBA; GINSENG; HEADACHE; HERB; HOT FLUSH; HUMAN; HYPERICUM PERFORATUM; HYPERLIPIDEMIA; INSOMNIA; LAW; MASTALGIA; MENORRHAGIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; RASH; REVIEW; SEXUAL DYSFUNCTION; VAGINAL DRYNESS; XEROSTOMIA;

EID: 0038734242     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2003.402     Document Type: Review

References (184)

1. Eisenberg DM, David RB, Ettner SL, et al: Trends in alternative medicine use in the United States, 1990-1997.JAMA 280:1569-1575, 1998
2. Druss BG, Rosenheck RA: Association between use of unconventional therapies and conventional medical services. JAMA 285:651-656, 1999
3. Astin JA: Why patients use alternative medicine: Results of a national study. JAMA 279:1548-1553, 1998
4. Brody JE: Americans gamble on herbs as medicine. New York Times February 9:2, 1999
5. Soller RW: Regulation in the herb market: The myth of the 'unregulated industry.' HerbalGram 49:64-67, 2000
6. Siegel R: Kola, ginseng, and mislabeled herbs. JAMA 237:24, 1978
7. DuPont R, Bogema S: Benzodiazapines in a health-catalog product. JAMA 264:959, 1990
8. Capobianco DJ, Brizis PW, Fox TP: Proximal muscle weakness induced by herbs. N Engl J Med 329:1430, 1993
9. Winslow LC, Kroll DJ: Herbs as medicines. Arch Intern Med 158:2192-2199, 1998
10. D'Arcy PF: Adverse reactions and interactions with herbal medicines, I: Adverse reactions. Adverse Drug React Toxicol Rev 10:189-208, 1991
11. Miller LG: Herbal medicinals: Selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 158:2200-2211, 1998
12. Ernst E: Harmless herbs? A review of the recent literature. Am J Med 104:170-178, 1998
13. Chase M: Health journal. Wall Street Journal November 16:B1, 1998
14. Blumenthal M, Gruenwald J, Hall T, et al (eds): The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA, Integrative Medicine Communications, 1998
15. Chung KF, McCusker M, Page CP, et al: Effect of ginkgolide mixture in antagonizing skin and platelet responses to platelet activating factor in man. Lancet 1:248-251, 1987
16. Schulz V, Hänsel R, Tyler VE: Rational phytotherapy: A physicians' guide to herbal medicine. New York, NY, Springer-Verlag
17. Blumenthal M: Herb sales down 3% in mass market retail stores - sales in natural food stores still growing, but at lower rate. HerbalGram 49:68, 2000
18. Kleinjen J, Knipschild P: Ginkgo biloba. Lancet 340:1136-1139, 1992
19. Kleinjen K, Knipschild P: Ginkgo biloba for cerebral insufficiency. Br J Clin Pharmacol 34:352-358, 1992
20. Rigney U, Kimber S, Hindmarch I: The effects of acute doses of standardized ginkgo biloba extract on memory and psychomotor performance in volunteers. Phytother Res 13:408-415, 1999
21. LeBars PL, Katz MM, Berman N, et al: A placebo-controlled, double-blind, randomized trial of an extract of ginkgo biloba for dementia. JAMA 278:1327-1332, 1997
22. Oken BS, Storzbach DM, Kaye JA: The efficacy of ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol 55:1409-1415, 1998
23. Ernst E, Pittler MH: Ginkgo biloba for dementia: A systematic review of double blind, placebo-controlled trials. Clinical Drug Investigation 17:301-308, 1999
24. Pittler MH, Ernst E: Ginkgo biloba extract for the treatment of intermittent claudication: A meta-analysis of randomized trials. Am J Med 108:276-281, 2000
25. Roncin JP, Schwartz F, D'Arbigny P: EGb 761 in control of acute mountain sickness and vascular reactivity to cold exposure. Aviat Space Environ Med 67:445-452, 1996
26. Cohen AJ, Bartilik BD: Gingko biloba for drug-induced sexual dysfunction. Presented at the American Psychiatric Association Annual Meeting, San Diego, CA, May 1997
27. Arenz A, Klein M, Fiehe K, et al: Occurrence of neurotoxic 4′-o-methylpyridoxine in ginkgo biloba leaves. Ginkgo medications and Japanese ginkgo food. Planta Med 62:548-551, 1996
28. Vale S: Subarachnonid hemorrhage associated with ginkgo biloba. Lancet 352:36, 1998
29. Rosenblatt M, Mindel J: Spontaneous hyphema associated with ingestion of ginkgo biloba extract [letter]. N Engl J Med 336:1108, 1997
30. Rowin J, Lewis SL: Spontaneous bilateral subdural hematomas associated with chronic ginkgo biloba ingestion have also occurred. Neurology 46:1775-1776, 1996
31. Matthews MK: Associate of ginkgo biloba with intracerebral hemorrhage. Neurology 50:1933-1934, 1998
32. Gilbert GJ: Ginkgo biloba (letter). Neurology, 48:1137, 1997
33. Jenike MA (ed): Hypericum: A novel antidepressant. J Geriatr Psychiatry Neurol 7:1-68, 1994 (suppl 1)
34. Laakmann G, Schule C, Baghai T, et al: St. John's Wort in mild to moderate depression: The relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry 31:54-59, 1998
35. Lenoir S, Degenring FH, Saller R: A double-blind randomised trial to investigate three different concentrations of a standardised fresh plant extract obtained from the shoots tips of Hypericum perforatum L. Phytomedicine 6:141-146, 1999
36. Müller WE, Singer A, Wonnemann M, et al: Hyperforin represents the neurotransmitter uptake inhibiting constituent of hypericum extract. Pharmacopsychiatry 31:16-21, 1998 (suppl)
37. Linde K, Gilbert R, Mulrow C, et al: St. John's Wort for depression: An overview and meta analysis of randomized clinical trials. BMJ 313:253-258, 1996
38. Linde K, Mulrow CD: Review: St. John's Wort for depression. The Cochrane Database of Systematic Reviews 2:1-38, 1999
39. Gaster B, Holroyd J: St. John's Wort for depression: A systematic review. Arch Intern Med 160:152-156, 2000
40. Ernst E: Herbal medicines: Where is the evidence? Growing evidence of effectiveness is counterbalanced by inadequate regulation. BMJ 321:395-396, 2000
41. Woelk H: Comparison of St. John's Wort and imipramine for treating depression: Randomised controlled trial. Remotiv/Imipramine Study Group. BMJ 321:536-539, 2000
42. Harrer G, Schmidt U, Kuhn U, et al: Comparison of equivalence between the St. John's Wort extract LoHyp-57 and fluoxetine. Arzneimittelforschung 49:289-296, 1999
43. Schrader E: Equivalence of a St. John's wort extract (Ze 117) and fluoxetine: A randomized, controlled study in mild-moderate depression. Int Clin Psychopharmacol 15:61-68, 2000
44. Stevinson C, Dixon M, Ernst E: Hypericum for fatigue - a pilot study. Phytomedicine 5:443-447, 1998
45. Hübner WP, Lande S, Poduweit H, et al: Hypericum treatment of mild depression with somatic symptoms. J Geriatr Psychiatry Neurol 7:12-14, 1994 (suppl 1)
46. Martinez B, Kasper S, Ruhrmann S, et al: Hypericum in the treatment of seasonal affective disorders. J Geriatr Psychiatry Neurol 7:29-33, 1994 (suppl 1)
47. Ernst E, Rand JI, Barnes J, et al: Adverse effects profile of the herbal antidepressant St John's wort (Hypericum perforatum L). Eur JClin Pharmacol 54:589-594, 1998
48. Bove GM: Acute neuropathy after exposure to sun in a patient treated with St. John's Worst [letter]. Lancet 352:1121-1122, 1998
49. Moses EL, Mallinger AG: St. John's Wort: Three cases of possible mania induction. J Clin Psychopharmacol 20:115-117, 2000
50. O'Breasail AM, Argouarch S: Hypomania and St. John's Wort. Can J Psychiatry 43:746-747, 1998
51. Schneck C: St. John's Wort and hypomania (letter). J Clin Psych 59:689, 1998
52. Lantz MS, Buchalter E, Giambanco V: St. John's Wort and anti-depressant drug interactions in the elderly. J Geriatr Psychiatry Neurol 12:7-10, 1999
53. Gordon JB: SSRIs and St. John's Wort: Possible toxicity [letter]? Am Fam Physician 57:950-953, 1998
54. Demott K: St John's wort tied to serotonin syndrome. Clinical Psychiatry News 26:28, 1998
55. Ernst E: Second thoughts about safety of St. John's Wort. Lancet 354:2014-2016, 1999
56. Johne A, Brockmöller J, Bauer S, et al: Pharmacokinetics and drug disposition: Pharmacokinetic interaction of digoxin with an herbal extract from St. John's Wort (hypericum perforatum). Clin Pharmacol Ther 66:338-345, 1999
57. Ruschitzka F, Meier PJ, Turina M, et al: Acute heart transplant rejection due to St. John's Wort. Lancet 355:548-549, 2000
58. Piscitelli SC, Burstein AH, Chaitt D, et al: Indinavar concentrations and St. John's Wort. Lancet 355:547-548, 2000
59. Yue QY, Bergquist C, Gerden B: Safety of St. John's wort. Lancet 355:576-577, 2000
60. Nebel A, Schneider BJ, Baker RA, et al: Potential metabolic interaction between St. John's wort and theophylline. Ann Pharmacother 33:502, 1999
61. Gregory PJ (ed): Drug interactions with St. John's Wort. Pharmacist's Letter/Prescriber's Letter. Stockton, CA, Therapeutic Research Center, 2000
62. Abramowicz M (ed): Drug interactions with St. John's Wort. The Medical Letter 42:56, 2000
63. Muscat M: St. John's Wort paces new wave of regulations. Altern Ther Health Med 6:27, 2000
64. National Institutes of Health: NIH Office of Dietary Supplements Announces Funding of Dietary Supplements Research Centers. NIH News Release, October 6, 1999. Bethesda, MD, National Institutes of Health. Available at www.nccam-info@nccam.nih.gov
65. Binaway C: NIH hypericum trial seeking participants. Duke Clinical Research Institute (letter to the editor). The Integrative Medicine Consult Feb:16, 2000
66. Hornig M: Hypericum (St. John's Wort) for treatment of depression. Alternative Medicine Alert 1:4-7, 1998
67. Mar C, Bent S: An evidence-based review of the 10 most commonly used herbs. WMJ 171:168-171, 1999
68. Li TSC, Harries D: Medicinal values of ginseng. The Herb, Spice, and Medicinal Plant Digest 14:1-5, 1996
69. Attele AS, Wu JA, Yuan CS: Ginseng pharmacology: Multiple constituents and multiple actions. Biochem Pharmacol 58:1685-1693, 1999
70. Lui J, Staba EJ: The ginsenosides of various ginseng plants and selected products. J Nat Prod 43:34-36, 1989
71. Vogler BK, Pittler MH, Ernst E: The efficacy of ginseng. A systematic review of randomised clinical trials. Eur JClin Pharmacol 55:567-575, 1999
72. Bahrke MS, Morgan WR: Evaluation of the ergogenic properties of ginseng: An update. Sports Med 29:113-133, 2000
73. Bucci LR: Selected herbals and human exercise performance. Am J Clin Nutr 72:624S-636S, 2000 (suppl 2)
74. Sotaniemi EA, Haapakkoski E, Rautio A: Ginseng therapy in non-insulin-independent diabetic patients. Diabetes Care 18:1373-1375, 1995
75. Vuksan V, Sievenpiper JL, Koo VY, et al: American ginseng (Panax quinquefolius L) reduces postprandial glycemia in non-diabetic subjects and subjects with type 2 diabetes mellitus. Arch Intern Med 160:1009-1013, 2000
76. Onomura M, Tsukada H, Fukuda K, et al: Effects of ginseng radix on sugar absorption in the small intestine. Am J Chin Med 27:347-354, 1999
77. Yun TK, Choi SY: Non-organ specific cancer prevention of ginseng: A prospective study in Korea. Int J Epidemiol 27:359-364, 1998
78. Wiklund IK, Mattsson LA, Lindgren R, et al: Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: A double-blind, placebo-controlled trial. Swedish Alternative Medicine Group. Int J Clin Pharmacol Res 19:89-99, 1999
79. Tode T, Kikuchi Y, Hirata J, et al: Effect of Korean red ginseng on psychological functions in patients with severe climacteric syndromes. Int J Gynaecol Obstet 67:169-174, 1999
80. Shin HR, Kim JY, Yun TK, et al: The cancer-preventive potential of Panax ginseng: A review of human and experimental evidence. Cancer Causes Control 11:565-576, 2000
81. Yun TK: Update from Asia. Asian studies on cancer chemoprevention (Review). Ann NY Acad Sci 889:157-192, 1992
82. Liu CX, Liu CX, Xiao PG, et al: Recent advances on ginseng research in China. J Ethnopharmacol 36:27-38, 1992
83. Punnonen R, Lukola A: Oestrogen-like effect of ginseng. BMJ 281:1110, 1978
84. Greenspan EM: Ginseng and vaginal bleeding. JAMA 249:2018, 1983
85. Hopkins MP, Androff L, Benninghoff AS: Ginseng face cream and unexplained vaginal bleeding. AmJ Obstet Gynecol 159:1121-1122, 1988
86. Palmer BV, Montgomery ACV, Monteiro JCMP: Ginseng and mastalgia. BMJ 1:1284, 1978
87. Koriech OM: Ginseng and mastalgia. BMJ 10:1556, 1978
88. Wilkie A, Cordess C: Ginseng - a root just like a carrot? J R Soc Med 87:594-595, 1994
89. Gonzales-Seijo JC, Ramos YM, Lastra I: Manic episode and ginseng: Report of a possible case. J Clin Psychopharmacol 15:447-448, 1995
90. Siegel RK: Ginseng abuse syndrome: Problems with the panacea. JAMA 241:1614-1615, 1979
91. McRae S: Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng. CMAJ 155:293-295, 1996
92. Janetzky K, Morreale AP: Probable interactions between warfarin and ginseng. Am J Health Syst Pharm 54:692-693, 1997
93. Jones BP, Runikis AM: Interaction of ginseng with phenelzine. J Clin Psychopharmacol 7:201-202, 1987
94. Schiedermayer D: Gingeng for the improvement of constitutional symptoms. Alternative Medicine Alert 1:37-41, 1998
95. Castleman M: Ginseng. Herb Quarterly 48:17-24, 1990
96. Koch HP in Lawson LD (ed): Garlic: The Science and Therapeutic Application of Allium Sativum L and Related Species (ed 2). Baltimore, MD, Williams & Wilkins, 1996
97. Gebhardt R: Multiple inhibitory effects of garlic extracts on cholesterol biosynthesis in hepatocytes. Lipids 28:613-619, 1993
98. Reuter MD: Allium sativum an allium ursinum, Part 2. Pharmacology and Medicinal Application. Phytomedicine 2:73-91, 1995
99. Bordia A: Effect of garlic on human platelet aggregation in vitro. Atherosclerosis 30:355-360, 1978
100. Koscielny J, Klübendorf D, Latza R, et al: The antiatherosclerotic effect of allium sativum. Atherosclerosis 144:237-249, 1999
101. Warshafsky S, Kamer RS, Sivak L: Effect of garlic on total serum cholesterol. Ann Intern Med 119:599-605, 1994
102. Silagy C, Neil A: Garlic as a lipid-lowering agent - a meta-analysis. J R Coll Physicians Lond 28:2-8, 1994
103. Jain AK, Vargas R, Gotzkowsky S, et al: Can garlic reduce levels of serum lipids? A controlled clinical study. AmJ Med 94:632-635, 1993
104. Adler AJ, Holub BJ: Effect of garlic and fish oil supplementation on serum lipid and lipoprotein concentrations in hypercholesterolemic men. AmJ Clin Nutr 65:445-450, 1997
105. Steiner M, Khan AH, Holbert D, et al: A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids. AmJ Clin Nutr 64:866-870, 1996
106. Simons LA, Balasubramanian S, von Konigsmark M, et al: On the effect of garlic on plasma lipids and lipoproteins in mild hypercholesterolemia. Atherosclerosis 113:219-225, 1995
107. Neil HA, Silagy CA, Lancaster T, et al: Garlic powder in the treatment of moderate hyperlipidemia: A controlled trial and meta-analysis. J R Coll Physicians London 30:329-334, 1996
108. Isaacsohn JL, Moser M, Stein EA, et al: Garlic powder and plasma lipids and lipoproteins: A multicenter, randomized, placebo-controlled trial. Arch Intern Med 158:1189-1194, 1998
109. Berthold HK, Sudhop K, vonBergmann K: Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism: A randomized controlled trial. JAMA 279:1900-1902, 1998
110. Superko HR, Krauss RM: Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein(a). J Am Coll Card 35:321-326, 2000
111. Lawson LD: Effect of garlic on serum lipids (letter). JAMA 290:1568, 1998
112. Stevinson C, Pittler MH, Ernst E: Garlic for treating hypercholesterolemia: A meta-analysis of randomized clinical trials. Ann Intern Med 133:420-429, 2000
113. Silagy C, Neil A: A meta-analysis of the effect of garlic on blood pressure. J Hypertens 12:463-468, 1994
114. Kleijnen J, Knipschild P, TerRiet G: Garlic, onions, and cardiovascular risk factors: A review of the evidence from human experiments with emphasis on commercially available preparations. Br J Clin Pharm 28:535-544, 1989
115. Jappe U, Bonnekoh B, Hausen BM, et al: Garlic-related dermatoses: Case report and review of the literature. Am J Contact Dermat 10:37-39, 1999
116. Perez-Pimiento AJ, Moneo I, Santaolalla M, et al: Anaphylactic reaction to young garlic. Allergy 54:626-629, 1999
117. Sunter WH: Warfarin and garlic (letter). Pharmaceutical Journal 246:722, 1999
118. Burnham BE: Garlic as a possible risk for postoperative bleeding. Plast Reconstr Surg 95:213, 1995
119. German K, Kuma U, Blackford HN: Garlic and the risk of TURP bleeding. Br J Urol 76:518, 1995
120. Rose KD, Croissant PD, Parliament CF, et al: Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: A case report. Neurosurgery 26:880-882, 1990
121. Foster S: Echinacea: Nature's Immune Enhancer. Rochester, VT, Health Arts Press, 1991
122. Braunig B: Echinacea purpurea radix for strengthening the immune response in flu-like infections. Zeitschrft fur Phytotherapie 13:7-13, 1992
123. Schoneberger D: The influence of the immunestimulating effects of pressed juices from echinacea purpurea on the course and intensity of the common cold: Results of a double-blind-clinical trial. Forum Immunologie 2:18-22, 1992
124. Kattapong JV: Echinacea for colds. Alternative Medicine Alert 3:128-130, 2000
125. Wacker A: Virus inhibition by echinea purpura. Planta Med 33:89-102, 1978
126. Melchart D, Linde K, Worku F, et al: Immunomodulation with echinacea - a systematic review of controlled clinical trials. Phytomedicine 1:245-254, 1994
127. Melchart D, Walther E, Linde K, et al: Echinacea root extracts for the prevention of upper respiratory tract infections. A double-blind, placebo-controlled randomized trial. Arch Fam Med 7:541-545, 1998
128. Hoheisel O, Sandberg M, Bertram S, et al: Echinacea treatment shortens the course of the common cold: A double-blind, placebo-controlled clinical trial. European Journal of Clinical Research 9:261-269, 1997
129. Turner RB, Risker RK, Gangemi JD, et al: Ineffectiveness of echinacea for prevention of experimental rhinovirus colds. Antimicrob Agents Chemother 44:1708-1709, 2000
130. Grimm W, Müller HH: A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections. Am J Med 106:138-143, 1999
131. Brinkeborn RM, Shah DV, Dengenring FH: Echinaforce® and other echinacea fresh plant preparations in the treatment of the common cold: A randomized, placebo controlled, double-blind clinical trial. Phytomedicine 6:1-5, 1999
132. Barrett B, Vohmann M, Calabrese C, et al: Echinacea for upper respiratory infection (Review of 9 treatment and 4 prevention trials). Fam Pract 48:628-635, 1999
133. Percival SS: Use of echinacea in medicine. Biochem Pharmacol 60:155-158, 2000
134. Muscat M: Botanical Products Development: SBBR and STTR. NCCAM Report. Altern Ther Health Med 6:23, 2000
135. Myers SP, Wohlmuth H: Echinacea associated anaphylaxis. Med J Aust 168:583-584, 1998
136. Mullins RJ: Echinacea-associated anaphylaxis. Med J Aust 168:170-171, 1998
137. AAAAI: Today's findings from the AAAAI annual meeting unveil new research on alternative therapies and food allergy: Echinaecea can cause allergic reactions [press release]. Milwaukee, WI, American Academy of Allergy, Asthma and Immunology, March 7, 2000
138. Houghton PJ: The biologic activity of valerian and related plants. J Ethnopharmacol 22:121-142, 1988
139. Santos MS, Ferreira F, Cunha AP, et al: An aqueous extract of valerian influences the transport of GABA in synaptosomes. Planta Med 60:278-279, 1994
140. Mennini T, Bernasconi P, Bomdardelli E, et al: In vitro study of interaction of extracts and pure compounds from valerian, a officinalis root with GABA, benzodiazepine and barbituate receptors in rat brain. Fitoterpia 54:291-300, 1993
141. Leathwood PD, Chauffard F, Heck E, et al: Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man. Pharmacol Biochem Behav 17:65-71, 1982
142. Leathwood PD, Chauffard F: Aqueous extract of valerian reduces sleep latency to fall asleep in man. Planta Med 50:144-148, 1984
143. Vorbach EU, Görtelmeyer R, Brünig J: Therapie von insomnien: Wirksamkeit und verträglichkeit eines baldrianpräparats. Psychopharmakotherapie 13:109-115, 1996
144. Hobbs C: Valerian: A literature review. HerbalGram 21:19-34, 1989
145. Hiller KO, Ketler G: Neuropharmacological studies on ethanol extracts of Valeriana officinalis L: Behavioural and anticonvulsant activities. Physiother Res Int 10:145-151, 1996
146. Capasso A, Defeo V, DeSimon F, et al: Pharmacological effects of aqueous extracts from Valeriana ascendens. Physiother Res Int 10:309-312, 1996
147. Felter H, Lloyd J: King's American Dispensatory (1898 ed). Sandy, OR, Eclectic Medical Publishing, 1992
148. Herrick JW: Iroquois Medical Botany. Syracuse, NY, Syracuse University Press, 1995, pp 119
149. Tyler V: Was Lydia E. Pinkham's vegetable compound an effective remedy? Pharmacy in History 37:24-28, 1998
150. Anonymous: Harvard Women's Health Watch. 7:6, 2000
151. Wade C, Kronenberg F, Kelly A, et al: Hormone-modulating herbs: Implications for women's health. JAMA 54:181-183, 1999
152. Jarry H, Harnischfeger G, Duker EM: The endocrine effects of constituents of cimicifuga racemosa: In vitro binding of constituents to estrogen receptors. Planta Med 4:316-319, 1985
153. Lehmann-Willenbrock E, Riedel H: Clinical and endocrinological examinations concerning therapy of climacteric symptoms following hysterectomy with remaining ovaries. Zentralbl Gynakol 110:611-618, 1988
154. Duker EM, Kopanski L, Jarry H, et al: Effects of extracts from cimicifuga racemosa on gonadotropin release in menopausal women and ovariectomized rats. Planta Med 57:420-424, 1991
155. Harnischfeger G, Cillien N: Influence of cimicifuga racemosa extract fractions on the proliferation of human carcinoma cells in vitro with regard to their estrogen receptor sensitivity. Paper presented at the 44th Annual Congress of Georg August Universitat, Gottingen, Germany, 1996
156. Nesselhut T, Schellhase T, Dietrich C, et al: Studies on mamma carcinoma cells regarding the proliferative potential of herbal medications with estrogen-like effects. Arch Gynecol Obstet 254:817-818, 1993
157. Schaper and Brummer: Scientific Brochure of Remifemin (English translation). Salzgitter, Germany, Schaper & Brummer, 1997
158. Dixon-Shanies D, Shaikh N: Growth inhibition of human breast cancer cells by herbs and phytoestrogens. Oncol Rep 6:1383-1387, 1999
159. Freudenstein J, Bodinet C: Influence of an isopropanolic aqueous extract of Cimicifuga racemosae rhizoma on the proliferation of MCF-7 cells. 23rd International LOF-Symposium on Phytoestrogens. University of Ghent, Belgium, 1999
160. Tillem J: Black cohosh for the treatment of perimenopausal and menopausal symptoms. Alternative Medicine Alert 3:17-19, 2000
161. Daiber W: Climacteric complaints: Success without using hormones! Arztliche Praxis 35:1946-1947, 1983
162. Petho A: Klimakterische beschwerden. Is change-over of a hormone treatment to an herbal gynecological remedy practicable? Arztliche Praxis 38:1551-1553, 1987
163. Stolze H: An alternative to treat menopausal complaints. Gynecology 3:14-16, 1982
164. Vorberg G: Successful hormone-free therapy with Remifemin. Zietschrift fuer Allgemeinmedizin 60:626-629, 1984
165. Warnecke G: Influence of phytotherapy on menopausal syndrome: Successful treatments with monoextract of cimicifuga. Medizinische Welt 36:871-874, 1985
166. Liske E: Therapeutic efficacy and safety of cimicifuga racemosa for gynecologic disorders. Advances in Natural Therapy 15:45-53, 1998
167. Stoll W: Phytopharmacon influences atrophic vaginal epithelium: Double-blind study - Cimicifuga vs estrogenic substances. Therapeuticum 1:23-31, 1987
168. Pepping J: Black cohosh: Cimicifuga racemosa. Am J Health Syst Pharm 56:1400-1402, 1999
169. McFarlin BL, Gibson MH, O'Rear J, et al: A national survey of herbal preparation use by nurse-midwives for labor stimulation. Review of the literature and recommendations for practice. Journal of Nurse-Midwifery 44:205-216, 1999
170. Brown DJ: Herbal research review: Vitex agnus castus clinical monograph. Quarterly Review of Natural Medicine Summer:111-121, 1994
171. Snow JM: Vitex agnus-castus L (Verbenaceae). Protocol Journal of Botanical Medicine 1:20-23, 1996
172. Gomaa CS, El-Moghazy MA, Halim FA, et al: Flavonoids and iridoids from Vitex agnus-castus. Planta Med 33:277, 1978
173. Chaste tree (monograph). The Review of Natural Products. St. Louis, MO, Facts & Comparisons, 1998
174. Jarry H, Leonhardt S, Gorkow C, et al: In vitro prolactin but not LH and FSH release is inhibited by compounds in extracts of Agnus castus: Direct evidence for dopaminergic principle by the dopamine receptor assay. Exp Clin Endocrinol Diabetes 102:448-454, 1994
175. Sliutz G, Speiser P, Schultz AM, et al: Agnus castus extracts inhibit prolactin secretion of rat pituitary cells. Horm Metab Res 25:253-255, 1993
176. Halbreich U: Serum prolactin in women with pre-menstrual syndrome. Lancet 2:654-656, 1976
177. Mayo J: Premenstrual syndrome: A natural approach to management. Clin Nutr Insights 5:1-8, 1997
178. Bohnert KJ: The use of Vitex agnus castus for hyperprolactinemia. Quarterly Review of Natural Medicine 19:21, 1997
179. Loch E, Bohnert KJ, Peeters M, et al: The treatment of menstrual disorders with Vitex agnus-castus tincture. Der Frauenarzt 32:867-870, 1991
180. Dittmar F, Bohnert KJ, Peeters M, et al: Premenstrual syndrome: Treatment with a phytopharmaceutical. Therapiewoche Gynakol 5:60-68, 1992
181. Peteres-Welter C, Albrecht M: Menstrual abnormalities and PMS. Vitex agnus castus in a study of application. Therapiewoche Gynakol 7:49-52, 1994
182. Feldmann HU, Albrecht M, Lamertz M, et al: The treatment of corpus luteum insufficiency and premenstrual syndrome. Experience in a multi-center study under clinical practice conditions (in German). Gynecologie 12:422-425, 1990
183. Laurtzen C, Reuter HD, Repges R, et al: Treatment of premenstrual tension syndrome with Vitex agnus castus. A controlled, double-blind study versus pyridoxine. Phytomedicine 4:183-189, 1997
184. Hardy ML: Herbs of special interest to women. J Am Pharm Assoc 40:234-242, 2000